Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs high-dose clopidogrel in AMI patients with CYP2C19 polymorphism
NCT00915733Phase 4Completed
- Sponsor
- Gyeongsang National University Hospital
- Start
- May 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in myocardial infarction (MI), sponsored by Gyeongsang National University Hospital. Started May 2009; status: completed.
02
Drugs
cilostazol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00915733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915733.